Globalink Investment Inc. stockholders approved a merger with Alps Life Sciences Inc. in a special meeting held on October 7, 2025, with all votes in favor totaling 3,445,007 shares. Following this, 59,966 shares were redeemed for cash, leaving 12,635 public shares outstanding.